RELEFACT TRH INJECTION 200MCG/ML
ODAN LABORATORIES LTD
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is RELEFACT TRH INJECTION 200MCG/ML discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that RELEFACT TRH INJECTION 200MCG/ML 0.2 mg/mL has been permanently discontinued (last updated October 5, 2017). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is RELEFACT TRH INJECTION 200MCG/ML not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
RELEFACT TRH INJ 0.2MG/ML
HOECHST CANADA INC.
RELEFACT TRH INJECTION 200MCG/ML
HOECHST ROUSSEL CANADA INC.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02224615
Strength
0.2 mg/mL
Dosage Form
Liquid
Route
I.V. injection
Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.